These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 30252758)

  • 21. Zoster vaccine protects against shingles.
    BMJ; 2013 Apr; 346():f2389. PubMed ID: 23596220
    [No Abstract]   [Full Text] [Related]  

  • 22. Which shingles vaccine for older adults?
    Le P
    BMJ; 2018 Oct; 363():k4203. PubMed ID: 30361204
    [No Abstract]   [Full Text] [Related]  

  • 23. Cost-effectiveness of herpes zoster vaccine: flawed assumptions regarding efficacy against postherpetic neuralgia.
    Brisson M; Pellissier JM; Levin MJ
    Clin Infect Dis; 2007 Dec; 45(11):1527-9. PubMed ID: 17990240
    [No Abstract]   [Full Text] [Related]  

  • 24. Recombinant Zoster Vaccine (Shingrix) to Prevent Herpes Zoster.
    Sly JR; Harris AL
    Nurs Womens Health; 2018 Oct; 22(5):417-422. PubMed ID: 30145235
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Update on the advisory committee on immunization practices' recommendations for use of herpes zoster vaccine.
    Weaver BA;
    J Am Osteopath Assoc; 2011 Oct; 111(10 Suppl 6):S31-3. PubMed ID: 22086893
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preventing herpes zoster through vaccination.
    Gelb LD
    Ophthalmology; 2008 Feb; 115(2 Suppl):S35-8. PubMed ID: 18243932
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stop shingles in its tracks.
    Lang PO; Hasso Y; Michel JP
    J Fam Pract; 2009 Oct; 58(10):531-4. PubMed ID: 19874731
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Herpes zoster and postherpetic neuralgia: prevention and management.
    Fashner J; Bell AL
    Am Fam Physician; 2011 Jun; 83(12):1432-7. PubMed ID: 21671543
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vaccination for preventing postherpetic neuralgia.
    Chen N; Li Q; Zhang Y; Zhou M; Zhou D; He L
    Cochrane Database Syst Rev; 2011 Mar; (3):CD007795. PubMed ID: 21412911
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Vaccination against Herpes Zoster after 50 years-of-age is effective].
    MMW Fortschr Med; 2015 Aug; 157(14):74-5. PubMed ID: 26289853
    [No Abstract]   [Full Text] [Related]  

  • 31. Herpes zoster vaccination among adults aged 60 years and older, in the U.S., 2008.
    Lu PJ; Euler GL; Harpaz R
    Am J Prev Med; 2011 Feb; 40(2):e1-6. PubMed ID: 21238856
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Herpes zoster and postherpetic neuralgia: advantages of the vaccination].
    Cañada JL
    Rev Esp Quimioter; 2009 Nov; 22 Suppl 1():19-21. PubMed ID: 20084344
    [No Abstract]   [Full Text] [Related]  

  • 33. [Vaccines against varicella-zoster virus (VZV)].
    Salleras L; Salleras M; Soldevila N; Prat A; Garrido P; Domínguez Á
    Enferm Infecc Microbiol Clin; 2015; 33(6):411-23. PubMed ID: 26096575
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Zoster vaccine live for the prevention of shingles in the elderly patient.
    Zussman J; Young L
    Clin Interv Aging; 2008; 3(2):241-50. PubMed ID: 18686747
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety of herpes zoster vaccine in the shingles prevention study: a randomized trial.
    Simberkoff MS; Arbeit RD; Johnson GR; Oxman MN; Boardman KD; Williams HM; Levin MJ; Schmader KE; Gelb LD; Keay S; Neuzil K; Greenberg RN; Griffin MR; Davis LE; Morrison VA; Annunziato PW;
    Ann Intern Med; 2010 May; 152(9):545-54. PubMed ID: 20439572
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel vaccine (Zostavax) to prevent herpes zoster and postherpetic neuralgia.
    Holcomb K; Weinberg JM
    J Drugs Dermatol; 2006 Oct; 5(9):863-6. PubMed ID: 17039651
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cost-effectiveness of vaccination against herpes zoster and postherpetic neuralgia: a critical review.
    Kawai K; Preaud E; Baron-Papillon F; Largeron N; Acosta CJ
    Vaccine; 2014 Mar; 32(15):1645-53. PubMed ID: 24534737
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Zostavax : a subcutaneous vaccine for the prevention of herpes zoster.
    Doan HQ; Ung B; Ramirez-Fort MK; Khan F; Tyring SK
    Expert Opin Biol Ther; 2013 Oct; 13(10):1467-77. PubMed ID: 23984934
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Practical references for Herpes zoster vaccination].
    MMW Fortschr Med; 2015 Aug; 157(14):75. PubMed ID: 26554071
    [No Abstract]   [Full Text] [Related]  

  • 40. Review of the Persistence of Herpes Zoster Vaccine Efficacy in Clinical Trials.
    Cook SJ; Flaherty DK
    Clin Ther; 2015 Nov; 37(11):2388-97. PubMed ID: 26602282
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.